Substratide

Research profile · Neuro & Cognitive

Semax

ACTH(4-10) analogue

Available as: 5mg, 10mg

Overview

A heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) based on a fragment of ACTH, developed in Russia and used there for stroke and cognitive disorders.

Mechanism

Increases BDNF and its receptor TrkB in the brain and modulates dopaminergic and serotonergic systems, without hormonal ACTH activity.

Research highlights

Compound data

Sequence
Met-Glu-His-Phe-Pro-Gly-Pro

Key paper: Dolotov OV et al., Brain Res 2006

All studies on PubMed